Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CIPLA vs SUN PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CIPLA SUN PHARMA CIPLA/
SUN PHARMA
 
P/E (TTM) x 32.4 54.0 60.1% View Chart
P/BV x 4.0 4.6 86.6% View Chart
Dividend Yield % 0.5 1.1 44.8%  

Financials

 CIPLA   SUN PHARMA
EQUITY SHARE DATA
    CIPLA
Mar-22
SUN PHARMA
Mar-22
CIPLA/
SUN PHARMA
5-Yr Chart
Click to enlarge
High Rs1,083931 116.4%   
Low Rs806593 136.0%   
Sales per share (Unadj.) Rs269.7161.1 167.4%  
Earnings per share (Unadj.) Rs31.714.2 223.5%  
Cash flow per share (Unadj.) Rs44.823.1 193.5%  
Dividends per share (Unadj.) Rs5.0010.00 50.0%  
Avg Dividend yield %0.51.3 40.3%  
Book value per share (Unadj.) Rs257.8200.1 128.8%  
Shares outstanding (eoy) m806.812,399.34 33.6%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.54.7 74.1%   
Avg P/E ratio x29.853.7 55.5%  
P/CF ratio (eoy) x21.132.9 64.1%  
Price / Book Value ratio x3.73.8 96.3%  
Dividend payout %15.870.4 22.4%   
Avg Mkt Cap Rs m762,1771,827,693 41.7%   
No. of employees `000NANA-   
Total wages/salary Rs m35,29973,008 48.3%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m217,633386,545 56.3%  
Other income Rs m3,21714,374 22.4%   
Total revenues Rs m220,851400,919 55.1%   
Gross profit Rs m43,29853,150 81.5%  
Depreciation Rs m10,52021,437 49.1%   
Interest Rs m1,0641,274 83.5%   
Profit before tax Rs m34,93344,813 78.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m9,33810,755 86.8%   
Profit after tax Rs m25,59534,058 75.1%  
Gross profit margin %19.913.7 144.7%  
Effective tax rate %26.724.0 111.4%   
Net profit margin %11.88.8 133.5%  
BALANCE SHEET DATA
Current assets Rs m147,108350,150 42.0%   
Current liabilities Rs m49,129172,006 28.6%   
Net working cap to sales %45.046.1 97.7%  
Current ratio x3.02.0 147.1%  
Inventory Days Days63149 42.2%  
Debtors Days Days6100 5.7%  
Net fixed assets Rs m119,415318,882 37.4%   
Share capital Rs m1,6142,399 67.3%   
"Free" reserves Rs m206,364477,713 43.2%   
Net worth Rs m207,977480,112 43.3%   
Long term debt Rs m4,1622,299 181.0%   
Total assets Rs m266,523669,032 39.8%  
Interest coverage x33.836.2 93.5%   
Debt to equity ratio x00 417.9%  
Sales to assets ratio x0.80.6 141.3%   
Return on assets %10.05.3 189.4%  
Return on equity %12.37.1 173.5%  
Return on capital %17.09.6 177.6%  
Exports to sales %26.20-   
Imports to sales %8.20-   
Exports (fob) Rs m57,094NA-   
Imports (cif) Rs m17,803NA-   
Fx inflow Rs m60,180106,331 56.6%   
Fx outflow Rs m17,80371,874 24.8%   
Net fx Rs m42,37634,456 123.0%   
CASH FLOW
From Operations Rs m33,25989,845 37.0%  
From Investments Rs m-18,719-57,247 32.7%  
From Financial Activity Rs m-15,998-51,935 30.8%  
Net Cashflow Rs m-1,323-17,648 7.5%  

Share Holding

Indian Promoters % 13.5 54.5 24.8%  
Foreign collaborators % 20.1 0.0 -  
Indian inst/Mut Fund % 49.0 34.6 141.5%  
FIIs % 27.6 15.0 184.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 66.4 45.5 145.8%  
Shareholders   418,910 647,167 64.7%  
Pledged promoter(s) holding % 0.0 4.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CIPLA With:   DR. REDDYS LAB    LUPIN    PIRAMAL ENTERPRISES    AUROBINDO PHARMA    ZYDUS LIFESCIENCES    



Today's Market

Sensex Zooms 418 Points, Nifty Ends Above 17,900; Bajaj Twins and Bharti Airtel Rally(Closing)

After opening the day on a flat note, Indian share markets extended gains as the session progressed and ended near day's high.